Page last updated: 2024-08-24

tobanum and Angor Pectoris

tobanum has been researched along with Angor Pectoris in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Büky, P; Gulyás, A; Sinkovics, M; Szám, I	1
Borvendég, J; Eggenhofer, J; Juvancz, P; Kósa, E; Szontagh, M; Török, E	2
Hollósi, Z; Iskum, M; Sipos, Z	1
Ol'binskaia, LI; Vartanova, OA	1

Trials

2 trial(s) available for tobanum and Angor Pectoris

Article	Year
Comparison of methods to detect side-effect on clinical application of chloranolol, a beta-adrenergic receptor inhibitor. European journal of clinical pharmacology, 1984, Volume: 26, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Central Nervous System; Digestive System; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines; Time Factors	1984
Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia. International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:12 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Central Nervous System Diseases; Clinical Trials as Topic; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Hypertension; Male; Middle Aged; Propanolamines	1985

Article

Year

Comparison of methods to detect side-effect on clinical application of chloranolol, a beta-adrenergic receptor inhibitor.

European journal of clinical pharmacology, 1984, Volume: 26, Issue:5

Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Central Nervous System; Digestive System; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines; Time Factors

1984

Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia.

International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:12

Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Central Nervous System Diseases; Clinical Trials as Topic; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Hypertension; Male; Middle Aged; Propanolamines

1985

Other Studies

3 other study(ies) available for tobanum and Angor Pectoris

Article	Year
Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration. International journal of clinical pharmacology, therapy, and toxicology, 1982, Volume: 20, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Electrocardiography; Female; Forced Expiratory Volume; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Neurocirculatory Asthenia; Propanolamines; Respiration	1982
Clinical examination of the beta-adrenergic receptor blocking activity of Tobanum in spontaneously occurring anginas. Therapia Hungarica (English edition), 1984, Volume: 32, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Female; Heart; Humans; Male; Middle Aged; Propanolamines	1984
[Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum]. Kardiologiia, 1986, Volume: 26, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Cardiac Complexes, Premature; Coronary Disease; Female; Heart; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol	1986